PHARMACEUTICAL BIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128929, encodeId=855121289298c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：还在编辑审稿中，速度稍慢，大家参考 28 September 2022 With Editor 24 October 2022 Out for Review 04 November 2022 Decision Pending 04 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 09 December 2022 With Editor 22 December 2022 Out for Review 07 February 2023 Decision Pending 10 February 2023 Revision Required 12 February 2023 Revision Incomplete 12 February 2023 Revised Manuscript Submitted 12 February 2023 With Journal Administrator 14 February 2023 With Editor 26 March 2023 Decision Pending 30 March 2023 Revision Required 03 April 2023 Revision Incomplete 03 April 2023 Revised Manuscript Submitted 03 April 2023 With Journal Administrator 06 April 2023 With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83eogh8I61BBtn7ZjdoGFpM5OQOvaYUoeh2rf23sibI1sxkojicnKAmQUKSotFPv3MFHzicImDIjqdYsjw/0, createdBy=18dd2208568, createdName=木木122, createdTime=Fri Apr 28 08:59:15 CST 2023, time=2023-04-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=507203, encodeId=e83050e203c1, content=我是该杂志的审稿人，给大家介绍点情况好了 1.这本杂志给审稿人的时间是30天，也就是说审稿还是很快的 2.杂志档次一般，审稿人和编辑大多比较nice 3.请认真对待审稿人意见，可以不认可，但是出言讽刺或者修改懈怠无异于no zuo no die 有其他问题可以在这里留言, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ca616, createdName=sirafu blade, createdTime=Fri Oct 31 11:41:00 CST 2014, time=2014-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2135975, encodeId=4ffc21359e595, content=偏重的研究方向：天然产物 经验分享：慎投真是大无语，前几天都小修只改格式了今天拒稿理由是我没有上传修改稿（然后没有任何理由)，系统问题直接给我拒稿服了，目前正在和编辑battle中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Tue May 16 23:27:17 CST 2023, time=2023-05-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1220254, encodeId=ff9b1220254a7, content=请问下大家都是提交多久后编辑开始处理稿件的呀？我这里提交了都一个多星期了编辑还没开始处理稿件，稿件的状态还是manuscript submitted，这也太慢了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Tue May 17 11:15:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200290, encodeId=fd48120029071, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志慢的让人绝望。我是21/8/7（研二）投稿，11/22大修，所有的意见都修改了，结果22/3/7号拒稿，还提出了一些新的问题，感觉不是一个审稿人，脱了6个多月最后拒稿，现在只能转投，学位证是拿不到了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ef35530683, createdName=Amelia Lee, createdTime=Mon Mar 07 17:49:31 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967398, encodeId=d53c96e39836, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：语言要求特别高！！！编辑很细心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Fri May 21 09:47:01 CST 2021, time=2021-05-21, status=1, ipAttribution=)]

2023-05-10 ms7000002028471868 来自安徽省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：中药提取物
经验分享：期待投中
19 March 2023
With Editor
14 April 2023
Out for Review
20 April 2023
Revision Required
25 April 2023
Revision Incomplete
25 April 2023
Revised Manuscript Submitted
25 April 2023
With Journal Administrator
28 April 2023
With Editor
29 April 2023
Out for Review
01 May 2023
Revision Required
01 May 2023
Revision Incomplete
01 May 2023
Revised Manuscript Submitted
01 May 2023
With Journal Administrator
02 May 2023
With Editor
02 May 2023
Out for Review
04 May 2023
Decision Pending

90 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128929, encodeId=855121289298c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：还在编辑审稿中，速度稍慢，大家参考 28 September 2022 With Editor 24 October 2022 Out for Review 04 November 2022 Decision Pending 04 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 09 December 2022 With Editor 22 December 2022 Out for Review 07 February 2023 Decision Pending 10 February 2023 Revision Required 12 February 2023 Revision Incomplete 12 February 2023 Revised Manuscript Submitted 12 February 2023 With Journal Administrator 14 February 2023 With Editor 26 March 2023 Decision Pending 30 March 2023 Revision Required 03 April 2023 Revision Incomplete 03 April 2023 Revised Manuscript Submitted 03 April 2023 With Journal Administrator 06 April 2023 With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83eogh8I61BBtn7ZjdoGFpM5OQOvaYUoeh2rf23sibI1sxkojicnKAmQUKSotFPv3MFHzicImDIjqdYsjw/0, createdBy=18dd2208568, createdName=木木122, createdTime=Fri Apr 28 08:59:15 CST 2023, time=2023-04-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=507203, encodeId=e83050e203c1, content=我是该杂志的审稿人，给大家介绍点情况好了 1.这本杂志给审稿人的时间是30天，也就是说审稿还是很快的 2.杂志档次一般，审稿人和编辑大多比较nice 3.请认真对待审稿人意见，可以不认可，但是出言讽刺或者修改懈怠无异于no zuo no die 有其他问题可以在这里留言, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ca616, createdName=sirafu blade, createdTime=Fri Oct 31 11:41:00 CST 2014, time=2014-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2135975, encodeId=4ffc21359e595, content=偏重的研究方向：天然产物 经验分享：慎投真是大无语，前几天都小修只改格式了今天拒稿理由是我没有上传修改稿（然后没有任何理由)，系统问题直接给我拒稿服了，目前正在和编辑battle中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Tue May 16 23:27:17 CST 2023, time=2023-05-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1220254, encodeId=ff9b1220254a7, content=请问下大家都是提交多久后编辑开始处理稿件的呀？我这里提交了都一个多星期了编辑还没开始处理稿件，稿件的状态还是manuscript submitted，这也太慢了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Tue May 17 11:15:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200290, encodeId=fd48120029071, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志慢的让人绝望。我是21/8/7（研二）投稿，11/22大修，所有的意见都修改了，结果22/3/7号拒稿，还提出了一些新的问题，感觉不是一个审稿人，脱了6个多月最后拒稿，现在只能转投，学位证是拿不到了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ef35530683, createdName=Amelia Lee, createdTime=Mon Mar 07 17:49:31 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967398, encodeId=d53c96e39836, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：语言要求特别高！！！编辑很细心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Fri May 21 09:47:01 CST 2021, time=2021-05-21, status=1, ipAttribution=)]

2023-04-28 木木122 来自陕西省

审稿速度:12.0 | 投稿命中率:50.0
经验分享：还在编辑审稿中，速度稍慢，大家参考
28 September 2022
With Editor
24 October 2022
Out for Review
04 November 2022
Decision Pending
04 November 2022
Revision Required
01 December 2022
Revision Incomplete
01 December 2022
Revised Manuscript Submitted
01 December 2022
With Journal Administrator
09 December 2022
With Editor
22 December 2022
Out for Review
07 February 2023
Decision Pending
10 February 2023
Revision Required
12 February 2023
Revision Incomplete
12 February 2023
Revised Manuscript Submitted
12 February 2023
With Journal Administrator
14 February 2023
With Editor
26 March 2023
Decision Pending
30 March 2023
Revision Required
03 April 2023
Revision Incomplete
03 April 2023
Revised Manuscript Submitted
03 April 2023
With Journal Administrator
06 April 2023
With Editor

57 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128929, encodeId=855121289298c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：还在编辑审稿中，速度稍慢，大家参考 28 September 2022 With Editor 24 October 2022 Out for Review 04 November 2022 Decision Pending 04 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 09 December 2022 With Editor 22 December 2022 Out for Review 07 February 2023 Decision Pending 10 February 2023 Revision Required 12 February 2023 Revision Incomplete 12 February 2023 Revised Manuscript Submitted 12 February 2023 With Journal Administrator 14 February 2023 With Editor 26 March 2023 Decision Pending 30 March 2023 Revision Required 03 April 2023 Revision Incomplete 03 April 2023 Revised Manuscript Submitted 03 April 2023 With Journal Administrator 06 April 2023 With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83eogh8I61BBtn7ZjdoGFpM5OQOvaYUoeh2rf23sibI1sxkojicnKAmQUKSotFPv3MFHzicImDIjqdYsjw/0, createdBy=18dd2208568, createdName=木木122, createdTime=Fri Apr 28 08:59:15 CST 2023, time=2023-04-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=507203, encodeId=e83050e203c1, content=我是该杂志的审稿人，给大家介绍点情况好了 1.这本杂志给审稿人的时间是30天，也就是说审稿还是很快的 2.杂志档次一般，审稿人和编辑大多比较nice 3.请认真对待审稿人意见，可以不认可，但是出言讽刺或者修改懈怠无异于no zuo no die 有其他问题可以在这里留言, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ca616, createdName=sirafu blade, createdTime=Fri Oct 31 11:41:00 CST 2014, time=2014-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2135975, encodeId=4ffc21359e595, content=偏重的研究方向：天然产物 经验分享：慎投真是大无语，前几天都小修只改格式了今天拒稿理由是我没有上传修改稿（然后没有任何理由)，系统问题直接给我拒稿服了，目前正在和编辑battle中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Tue May 16 23:27:17 CST 2023, time=2023-05-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1220254, encodeId=ff9b1220254a7, content=请问下大家都是提交多久后编辑开始处理稿件的呀？我这里提交了都一个多星期了编辑还没开始处理稿件，稿件的状态还是manuscript submitted，这也太慢了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Tue May 17 11:15:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200290, encodeId=fd48120029071, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志慢的让人绝望。我是21/8/7（研二）投稿，11/22大修，所有的意见都修改了，结果22/3/7号拒稿，还提出了一些新的问题，感觉不是一个审稿人，脱了6个多月最后拒稿，现在只能转投，学位证是拿不到了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ef35530683, createdName=Amelia Lee, createdTime=Mon Mar 07 17:49:31 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967398, encodeId=d53c96e39836, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：语言要求特别高！！！编辑很细心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Fri May 21 09:47:01 CST 2021, time=2021-05-21, status=1, ipAttribution=)]

2014-10-31 sirafu blade

我是该杂志的审稿人，给大家介绍点情况好了

1.这本杂志给审稿人的时间是30天，也就是说审稿还是很快的
2.杂志档次一般，审稿人和编辑大多比较nice
3.请认真对待审稿人意见，可以不认可，但是出言讽刺或者修改懈怠无异于no zuo no die

有其他问题可以在这里留言

434 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128929, encodeId=855121289298c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：还在编辑审稿中，速度稍慢，大家参考 28 September 2022 With Editor 24 October 2022 Out for Review 04 November 2022 Decision Pending 04 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 09 December 2022 With Editor 22 December 2022 Out for Review 07 February 2023 Decision Pending 10 February 2023 Revision Required 12 February 2023 Revision Incomplete 12 February 2023 Revised Manuscript Submitted 12 February 2023 With Journal Administrator 14 February 2023 With Editor 26 March 2023 Decision Pending 30 March 2023 Revision Required 03 April 2023 Revision Incomplete 03 April 2023 Revised Manuscript Submitted 03 April 2023 With Journal Administrator 06 April 2023 With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83eogh8I61BBtn7ZjdoGFpM5OQOvaYUoeh2rf23sibI1sxkojicnKAmQUKSotFPv3MFHzicImDIjqdYsjw/0, createdBy=18dd2208568, createdName=木木122, createdTime=Fri Apr 28 08:59:15 CST 2023, time=2023-04-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=507203, encodeId=e83050e203c1, content=我是该杂志的审稿人，给大家介绍点情况好了 1.这本杂志给审稿人的时间是30天，也就是说审稿还是很快的 2.杂志档次一般，审稿人和编辑大多比较nice 3.请认真对待审稿人意见，可以不认可，但是出言讽刺或者修改懈怠无异于no zuo no die 有其他问题可以在这里留言, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ca616, createdName=sirafu blade, createdTime=Fri Oct 31 11:41:00 CST 2014, time=2014-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2135975, encodeId=4ffc21359e595, content=偏重的研究方向：天然产物 经验分享：慎投真是大无语，前几天都小修只改格式了今天拒稿理由是我没有上传修改稿（然后没有任何理由)，系统问题直接给我拒稿服了，目前正在和编辑battle中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Tue May 16 23:27:17 CST 2023, time=2023-05-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1220254, encodeId=ff9b1220254a7, content=请问下大家都是提交多久后编辑开始处理稿件的呀？我这里提交了都一个多星期了编辑还没开始处理稿件，稿件的状态还是manuscript submitted，这也太慢了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Tue May 17 11:15:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200290, encodeId=fd48120029071, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志慢的让人绝望。我是21/8/7（研二）投稿，11/22大修，所有的意见都修改了，结果22/3/7号拒稿，还提出了一些新的问题，感觉不是一个审稿人，脱了6个多月最后拒稿，现在只能转投，学位证是拿不到了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ef35530683, createdName=Amelia Lee, createdTime=Mon Mar 07 17:49:31 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967398, encodeId=d53c96e39836, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：语言要求特别高！！！编辑很细心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Fri May 21 09:47:01 CST 2021, time=2021-05-21, status=1, ipAttribution=)]

2022-04-22 Dr.Ding Jin

偏重的研究方向：中药复方
经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？

127 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128929, encodeId=855121289298c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：还在编辑审稿中，速度稍慢，大家参考 28 September 2022 With Editor 24 October 2022 Out for Review 04 November 2022 Decision Pending 04 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 09 December 2022 With Editor 22 December 2022 Out for Review 07 February 2023 Decision Pending 10 February 2023 Revision Required 12 February 2023 Revision Incomplete 12 February 2023 Revised Manuscript Submitted 12 February 2023 With Journal Administrator 14 February 2023 With Editor 26 March 2023 Decision Pending 30 March 2023 Revision Required 03 April 2023 Revision Incomplete 03 April 2023 Revised Manuscript Submitted 03 April 2023 With Journal Administrator 06 April 2023 With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83eogh8I61BBtn7ZjdoGFpM5OQOvaYUoeh2rf23sibI1sxkojicnKAmQUKSotFPv3MFHzicImDIjqdYsjw/0, createdBy=18dd2208568, createdName=木木122, createdTime=Fri Apr 28 08:59:15 CST 2023, time=2023-04-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=507203, encodeId=e83050e203c1, content=我是该杂志的审稿人，给大家介绍点情况好了 1.这本杂志给审稿人的时间是30天，也就是说审稿还是很快的 2.杂志档次一般，审稿人和编辑大多比较nice 3.请认真对待审稿人意见，可以不认可，但是出言讽刺或者修改懈怠无异于no zuo no die 有其他问题可以在这里留言, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ca616, createdName=sirafu blade, createdTime=Fri Oct 31 11:41:00 CST 2014, time=2014-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2135975, encodeId=4ffc21359e595, content=偏重的研究方向：天然产物 经验分享：慎投真是大无语，前几天都小修只改格式了今天拒稿理由是我没有上传修改稿（然后没有任何理由)，系统问题直接给我拒稿服了，目前正在和编辑battle中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Tue May 16 23:27:17 CST 2023, time=2023-05-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1220254, encodeId=ff9b1220254a7, content=请问下大家都是提交多久后编辑开始处理稿件的呀？我这里提交了都一个多星期了编辑还没开始处理稿件，稿件的状态还是manuscript submitted，这也太慢了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Tue May 17 11:15:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200290, encodeId=fd48120029071, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志慢的让人绝望。我是21/8/7（研二）投稿，11/22大修，所有的意见都修改了，结果22/3/7号拒稿，还提出了一些新的问题，感觉不是一个审稿人，脱了6个多月最后拒稿，现在只能转投，学位证是拿不到了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ef35530683, createdName=Amelia Lee, createdTime=Mon Mar 07 17:49:31 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967398, encodeId=d53c96e39836, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：语言要求特别高！！！编辑很细心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Fri May 21 09:47:01 CST 2021, time=2021-05-21, status=1, ipAttribution=)]

2023-03-20 ms5000000768384636 来自四川省

审稿速度:3.0
经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。

49 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128929, encodeId=855121289298c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：还在编辑审稿中，速度稍慢，大家参考 28 September 2022 With Editor 24 October 2022 Out for Review 04 November 2022 Decision Pending 04 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 09 December 2022 With Editor 22 December 2022 Out for Review 07 February 2023 Decision Pending 10 February 2023 Revision Required 12 February 2023 Revision Incomplete 12 February 2023 Revised Manuscript Submitted 12 February 2023 With Journal Administrator 14 February 2023 With Editor 26 March 2023 Decision Pending 30 March 2023 Revision Required 03 April 2023 Revision Incomplete 03 April 2023 Revised Manuscript Submitted 03 April 2023 With Journal Administrator 06 April 2023 With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83eogh8I61BBtn7ZjdoGFpM5OQOvaYUoeh2rf23sibI1sxkojicnKAmQUKSotFPv3MFHzicImDIjqdYsjw/0, createdBy=18dd2208568, createdName=木木122, createdTime=Fri Apr 28 08:59:15 CST 2023, time=2023-04-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=507203, encodeId=e83050e203c1, content=我是该杂志的审稿人，给大家介绍点情况好了 1.这本杂志给审稿人的时间是30天，也就是说审稿还是很快的 2.杂志档次一般，审稿人和编辑大多比较nice 3.请认真对待审稿人意见，可以不认可，但是出言讽刺或者修改懈怠无异于no zuo no die 有其他问题可以在这里留言, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ca616, createdName=sirafu blade, createdTime=Fri Oct 31 11:41:00 CST 2014, time=2014-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2135975, encodeId=4ffc21359e595, content=偏重的研究方向：天然产物 经验分享：慎投真是大无语，前几天都小修只改格式了今天拒稿理由是我没有上传修改稿（然后没有任何理由)，系统问题直接给我拒稿服了，目前正在和编辑battle中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Tue May 16 23:27:17 CST 2023, time=2023-05-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1220254, encodeId=ff9b1220254a7, content=请问下大家都是提交多久后编辑开始处理稿件的呀？我这里提交了都一个多星期了编辑还没开始处理稿件，稿件的状态还是manuscript submitted，这也太慢了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Tue May 17 11:15:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200290, encodeId=fd48120029071, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志慢的让人绝望。我是21/8/7（研二）投稿，11/22大修，所有的意见都修改了，结果22/3/7号拒稿，还提出了一些新的问题，感觉不是一个审稿人，脱了6个多月最后拒稿，现在只能转投，学位证是拿不到了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ef35530683, createdName=Amelia Lee, createdTime=Mon Mar 07 17:49:31 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967398, encodeId=d53c96e39836, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：语言要求特别高！！！编辑很细心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Fri May 21 09:47:01 CST 2021, time=2021-05-21, status=1, ipAttribution=)]

2023-05-16 ms8000002023702013 来自四川省

偏重的研究方向：天然产物
经验分享：慎投真是大无语，前几天都小修只改格式了今天拒稿理由是我没有上传修改稿（然后没有任何理由)，系统问题直接给我拒稿服了，目前正在和编辑battle中

36 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128929, encodeId=855121289298c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：还在编辑审稿中，速度稍慢，大家参考 28 September 2022 With Editor 24 October 2022 Out for Review 04 November 2022 Decision Pending 04 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 09 December 2022 With Editor 22 December 2022 Out for Review 07 February 2023 Decision Pending 10 February 2023 Revision Required 12 February 2023 Revision Incomplete 12 February 2023 Revised Manuscript Submitted 12 February 2023 With Journal Administrator 14 February 2023 With Editor 26 March 2023 Decision Pending 30 March 2023 Revision Required 03 April 2023 Revision Incomplete 03 April 2023 Revised Manuscript Submitted 03 April 2023 With Journal Administrator 06 April 2023 With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83eogh8I61BBtn7ZjdoGFpM5OQOvaYUoeh2rf23sibI1sxkojicnKAmQUKSotFPv3MFHzicImDIjqdYsjw/0, createdBy=18dd2208568, createdName=木木122, createdTime=Fri Apr 28 08:59:15 CST 2023, time=2023-04-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=507203, encodeId=e83050e203c1, content=我是该杂志的审稿人，给大家介绍点情况好了 1.这本杂志给审稿人的时间是30天，也就是说审稿还是很快的 2.杂志档次一般，审稿人和编辑大多比较nice 3.请认真对待审稿人意见，可以不认可，但是出言讽刺或者修改懈怠无异于no zuo no die 有其他问题可以在这里留言, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ca616, createdName=sirafu blade, createdTime=Fri Oct 31 11:41:00 CST 2014, time=2014-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2135975, encodeId=4ffc21359e595, content=偏重的研究方向：天然产物 经验分享：慎投真是大无语，前几天都小修只改格式了今天拒稿理由是我没有上传修改稿（然后没有任何理由)，系统问题直接给我拒稿服了，目前正在和编辑battle中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Tue May 16 23:27:17 CST 2023, time=2023-05-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1220254, encodeId=ff9b1220254a7, content=请问下大家都是提交多久后编辑开始处理稿件的呀？我这里提交了都一个多星期了编辑还没开始处理稿件，稿件的状态还是manuscript submitted，这也太慢了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Tue May 17 11:15:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200290, encodeId=fd48120029071, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志慢的让人绝望。我是21/8/7（研二）投稿，11/22大修，所有的意见都修改了，结果22/3/7号拒稿，还提出了一些新的问题，感觉不是一个审稿人，脱了6个多月最后拒稿，现在只能转投，学位证是拿不到了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ef35530683, createdName=Amelia Lee, createdTime=Mon Mar 07 17:49:31 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967398, encodeId=d53c96e39836, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：语言要求特别高！！！编辑很细心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Fri May 21 09:47:01 CST 2021, time=2021-05-21, status=1, ipAttribution=)]

2023-06-05 hongzhongshi 来自福建省

审稿速度:3.0 | 投稿命中率:5.0
偏重的研究方向：中药提取物
经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了

43 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128929, encodeId=855121289298c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：还在编辑审稿中，速度稍慢，大家参考 28 September 2022 With Editor 24 October 2022 Out for Review 04 November 2022 Decision Pending 04 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 09 December 2022 With Editor 22 December 2022 Out for Review 07 February 2023 Decision Pending 10 February 2023 Revision Required 12 February 2023 Revision Incomplete 12 February 2023 Revised Manuscript Submitted 12 February 2023 With Journal Administrator 14 February 2023 With Editor 26 March 2023 Decision Pending 30 March 2023 Revision Required 03 April 2023 Revision Incomplete 03 April 2023 Revised Manuscript Submitted 03 April 2023 With Journal Administrator 06 April 2023 With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83eogh8I61BBtn7ZjdoGFpM5OQOvaYUoeh2rf23sibI1sxkojicnKAmQUKSotFPv3MFHzicImDIjqdYsjw/0, createdBy=18dd2208568, createdName=木木122, createdTime=Fri Apr 28 08:59:15 CST 2023, time=2023-04-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=507203, encodeId=e83050e203c1, content=我是该杂志的审稿人，给大家介绍点情况好了 1.这本杂志给审稿人的时间是30天，也就是说审稿还是很快的 2.杂志档次一般，审稿人和编辑大多比较nice 3.请认真对待审稿人意见，可以不认可，但是出言讽刺或者修改懈怠无异于no zuo no die 有其他问题可以在这里留言, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ca616, createdName=sirafu blade, createdTime=Fri Oct 31 11:41:00 CST 2014, time=2014-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2135975, encodeId=4ffc21359e595, content=偏重的研究方向：天然产物 经验分享：慎投真是大无语，前几天都小修只改格式了今天拒稿理由是我没有上传修改稿（然后没有任何理由)，系统问题直接给我拒稿服了，目前正在和编辑battle中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Tue May 16 23:27:17 CST 2023, time=2023-05-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1220254, encodeId=ff9b1220254a7, content=请问下大家都是提交多久后编辑开始处理稿件的呀？我这里提交了都一个多星期了编辑还没开始处理稿件，稿件的状态还是manuscript submitted，这也太慢了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Tue May 17 11:15:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200290, encodeId=fd48120029071, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志慢的让人绝望。我是21/8/7（研二）投稿，11/22大修，所有的意见都修改了，结果22/3/7号拒稿，还提出了一些新的问题，感觉不是一个审稿人，脱了6个多月最后拒稿，现在只能转投，学位证是拿不到了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ef35530683, createdName=Amelia Lee, createdTime=Mon Mar 07 17:49:31 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967398, encodeId=d53c96e39836, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：语言要求特别高！！！编辑很细心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Fri May 21 09:47:01 CST 2021, time=2021-05-21, status=1, ipAttribution=)]

2022-05-17 1207b607m24(暂无昵称)

请问下大家都是提交多久后编辑开始处理稿件的呀？我这里提交了都一个多星期了编辑还没开始处理稿件，稿件的状态还是manuscript submitted，这也太慢了吧。。。

96 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128929, encodeId=855121289298c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：还在编辑审稿中，速度稍慢，大家参考 28 September 2022 With Editor 24 October 2022 Out for Review 04 November 2022 Decision Pending 04 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 09 December 2022 With Editor 22 December 2022 Out for Review 07 February 2023 Decision Pending 10 February 2023 Revision Required 12 February 2023 Revision Incomplete 12 February 2023 Revised Manuscript Submitted 12 February 2023 With Journal Administrator 14 February 2023 With Editor 26 March 2023 Decision Pending 30 March 2023 Revision Required 03 April 2023 Revision Incomplete 03 April 2023 Revised Manuscript Submitted 03 April 2023 With Journal Administrator 06 April 2023 With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83eogh8I61BBtn7ZjdoGFpM5OQOvaYUoeh2rf23sibI1sxkojicnKAmQUKSotFPv3MFHzicImDIjqdYsjw/0, createdBy=18dd2208568, createdName=木木122, createdTime=Fri Apr 28 08:59:15 CST 2023, time=2023-04-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=507203, encodeId=e83050e203c1, content=我是该杂志的审稿人，给大家介绍点情况好了 1.这本杂志给审稿人的时间是30天，也就是说审稿还是很快的 2.杂志档次一般，审稿人和编辑大多比较nice 3.请认真对待审稿人意见，可以不认可，但是出言讽刺或者修改懈怠无异于no zuo no die 有其他问题可以在这里留言, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ca616, createdName=sirafu blade, createdTime=Fri Oct 31 11:41:00 CST 2014, time=2014-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2135975, encodeId=4ffc21359e595, content=偏重的研究方向：天然产物 经验分享：慎投真是大无语，前几天都小修只改格式了今天拒稿理由是我没有上传修改稿（然后没有任何理由)，系统问题直接给我拒稿服了，目前正在和编辑battle中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Tue May 16 23:27:17 CST 2023, time=2023-05-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1220254, encodeId=ff9b1220254a7, content=请问下大家都是提交多久后编辑开始处理稿件的呀？我这里提交了都一个多星期了编辑还没开始处理稿件，稿件的状态还是manuscript submitted，这也太慢了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Tue May 17 11:15:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200290, encodeId=fd48120029071, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志慢的让人绝望。我是21/8/7（研二）投稿，11/22大修，所有的意见都修改了，结果22/3/7号拒稿，还提出了一些新的问题，感觉不是一个审稿人，脱了6个多月最后拒稿，现在只能转投，学位证是拿不到了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ef35530683, createdName=Amelia Lee, createdTime=Mon Mar 07 17:49:31 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967398, encodeId=d53c96e39836, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：语言要求特别高！！！编辑很细心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Fri May 21 09:47:01 CST 2021, time=2021-05-21, status=1, ipAttribution=)]

2022-03-07 Amelia Lee

审稿速度:6.0 | 投稿命中率:25.0
经验分享：这个杂志慢的让人绝望。我是21/8/7（研二）投稿，11/22大修，所有的意见都修改了，结果22/3/7号拒稿，还提出了一些新的问题，感觉不是一个审稿人，脱了6个多月最后拒稿，现在只能转投，学位证是拿不到了

113 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2128929, encodeId=855121289298c, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：还在编辑审稿中，速度稍慢，大家参考 28 September 2022 With Editor 24 October 2022 Out for Review 04 November 2022 Decision Pending 04 November 2022 Revision Required 01 December 2022 Revision Incomplete 01 December 2022 Revised Manuscript Submitted 01 December 2022 With Journal Administrator 09 December 2022 With Editor 22 December 2022 Out for Review 07 February 2023 Decision Pending 10 February 2023 Revision Required 12 February 2023 Revision Incomplete 12 February 2023 Revised Manuscript Submitted 12 February 2023 With Journal Administrator 14 February 2023 With Editor 26 March 2023 Decision Pending 30 March 2023 Revision Required 03 April 2023 Revision Incomplete 03 April 2023 Revised Manuscript Submitted 03 April 2023 With Journal Administrator 06 April 2023 With Editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83eogh8I61BBtn7ZjdoGFpM5OQOvaYUoeh2rf23sibI1sxkojicnKAmQUKSotFPv3MFHzicImDIjqdYsjw/0, createdBy=18dd2208568, createdName=木木122, createdTime=Fri Apr 28 08:59:15 CST 2023, time=2023-04-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=507203, encodeId=e83050e203c1, content=我是该杂志的审稿人，给大家介绍点情况好了 1.这本杂志给审稿人的时间是30天，也就是说审稿还是很快的 2.杂志档次一般，审稿人和编辑大多比较nice 3.请认真对待审稿人意见，可以不认可，但是出言讽刺或者修改懈怠无异于no zuo no die 有其他问题可以在这里留言, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ca616, createdName=sirafu blade, createdTime=Fri Oct 31 11:41:00 CST 2014, time=2014-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120664, encodeId=baf12120664b2, content=审稿速度:3.0 经验分享：投稿时，在编辑那里修改了几次格式问题。做复方有液相，外审70天，目前小修中，持续更新后续。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=ms5000000768384636, createdTime=Mon Mar 20 23:40:09 CST 2023, time=2023-03-20, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2135975, encodeId=4ffc21359e595, content=偏重的研究方向：天然产物 经验分享：慎投真是大无语，前几天都小修只改格式了今天拒稿理由是我没有上传修改稿（然后没有任何理由)，系统问题直接给我拒稿服了，目前正在和编辑battle中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71206511428, createdName=ms8000002023702013, createdTime=Tue May 16 23:27:17 CST 2023, time=2023-05-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2140925, encodeId=b41121409254c, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：中药提取物 经验分享：审稿人一个同意发表，一个建议修回补实验，补完实验修回去，编辑无理由拒稿，就说unsuitable。无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Mon Jun 05 17:42:05 CST 2023, time=2023-06-05, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1220254, encodeId=ff9b1220254a7, content=请问下大家都是提交多久后编辑开始处理稿件的呀？我这里提交了都一个多星期了编辑还没开始处理稿件，稿件的状态还是manuscript submitted，这也太慢了吧。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=740f2183710, createdName=1207b607m24(暂无昵称), createdTime=Tue May 17 11:15:33 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200290, encodeId=fd48120029071, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：这个杂志慢的让人绝望。我是21/8/7（研二）投稿，11/22大修，所有的意见都修改了，结果22/3/7号拒稿，还提出了一些新的问题，感觉不是一个审稿人，脱了6个多月最后拒稿，现在只能转投，学位证是拿不到了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ef35530683, createdName=Amelia Lee, createdTime=Mon Mar 07 17:49:31 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967398, encodeId=d53c96e39836, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：药理 经验分享：语言要求特别高！！！编辑很细心。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c8280048, createdName=zqlee, createdTime=Fri May 21 09:47:01 CST 2021, time=2021-05-21, status=1, ipAttribution=)]

2021-05-21 zqlee

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：药理
经验分享：语言要求特别高！！！编辑很细心。

61 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务